Medicine Man Technologies, Inc.
SHWZ · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.02 | -0.00 | 0.55 |
| FCF Yield | -2.29% | -8.91% | 5.27% | 3.16% |
| EV / EBITDA | 51.38 | 101.03 | -17.73 | 11.22 |
| Quality | ||||
| ROIC | -1.34% | -1.20% | -6.16% | -0.17% |
| Gross Margin | 44.05% | 43.11% | -4.85% | 45.86% |
| Cash Conversion Ratio | 0.01 | 0.23 | -0.12 | -21.54 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.18% | 12.93% | 16.73% | 23.51% |
| Free Cash Flow Growth | 86.15% | -327.22% | 5.49% | 144.53% |
| Safety | ||||
| Net Debt / EBITDA | 43.91 | 76.43 | -14.14 | 7.89 |
| Interest Coverage | -0.33 | -0.33 | -2.00 | 1.07 |
| Efficiency | ||||
| Inventory Turnover | 0.97 | 0.90 | 1.76 | 0.77 |
| Cash Conversion Cycle | 71.85 | 71.67 | 33.51 | 84.68 |